600351-基本财务实时评分详情
亚宝药业600351基本财务实时评分详情
更新时间:2022-01-20 00:00:01
股票代码
600351
当期评分
股票名称
亚宝药业
报告日期2018-12-312019-12-312020-09-302020-09-302020-09-302020-09-30
每股经营现金流(¥)0.5420.55220.30590.30590.3059
销售净利润率(%)9.7330.3554.8624.8624.862
销售毛利率(%)58.644362.291158.951258.951258.9512
净资产收益率(%)9.440.523.323.323.32
营业增长率(%)14.05444.2431-20.4084-20.4084-20.4084
净利润增长率(%)42.1373-96.1979-59.9985-59.9985-59.9985
每股收益(%)0.34830.01790.07930.05190.1193
现金流量比率(%)25.217128.825114.37035.616620.5204
三项费用比重(%)43.650248.209150.787150.61550.741
每股净资产(¥)3.68023.49223.55143.5443.5914
流动比率(%)1.38751.40331.46761.42651.6186
速动比率(%)1.05841.02261.10321.081.1714
现金比率(%)46.637732.862443.601938.884638.8846
总资产利润率(%)6.17780.23631.38980.90622.153
主营利润比重%518.62973799.147966.17832.72891021.9688
应收账款(万元)59,617.9256,314.6857,990.9162,091.0264,139.53
应收票据(万元)31,415.864,821.033,344.962,311.163,424.75
预付款项(万元)3,139.594,206.497,709.395,202.358,567.80
存货(万元)55,684.4556,166.1350,697.9751,557.4251,330.87
在建工程(万元)5,605.842,885.795,136.184,385.825,645.17
应付款项(万元)21,663.2414,355.3912,091.1511,989.8014,033.60
长期借款(万元)1,984.441,967.161,500.001,967.161,500.00
未分配利润(万元)95,137.3376,968.5881,532.6980,967.1684,617.68
商誉(万元)33,076.186,699.526,699.526,699.526,699.52
流动资产(万元)247,896.34224,271.50222,068.66224,037.86219,175.16
流动负债(万元)169,171.81147,500.02139,130.87148,791.39114,785.55
亚宝药业600351评分结果
48.48分
卖出/减持

copyright@ YOUVERY TECHNOLOGY CO., 厦门优极网络科技有限公司©
闽ICP备17005296号-3
地址:厦门市湖里区高崎道890号 邮编:361006